Minoru Tobiume

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Strain Traits of Intracranially Administered L-Type Bovine Spongiform Encephalopathy Prions Are not Significantly Modified During Intraspecies Transmission in Cynomolgus Monkeys.

Strain Traits of Intracranially Administered L-Type Bovine Spongiform Encephalopathy Prions Are not Significantly Modified During Intraspecies Transmission in Cynomolgus Monkeys.

Journal: Microbiology and immunology
Published: October 27, 2025

Administration of L-Type Bovine Spongiform Encephalopathy to Macaques to Evaluate Zoonotic Potential.

Administration of L-Type Bovine Spongiform Encephalopathy to Macaques to Evaluate Zoonotic Potential.

Journal: Emerging infectious diseases
Published: April 30, 2025

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens.

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens.

Journal: Scientific reports
Published: December 05, 2024

Lack of Evidence for Transmission of Atypical H-Type Bovine Spongiform Encephalopathy Prions (H-BSE Prions) by Intracranial and Oral Challenges to Nonhuman Primates.

Lack of Evidence for Transmission of Atypical H-Type Bovine Spongiform Encephalopathy Prions (H-BSE Prions) by Intracranial and Oral Challenges to Nonhuman Primates.

Journal: Microbiology and immunology
Published: August 22, 2024

Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.

Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.

Journal: Scientific reports
Published: June 14, 2024

Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.

Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 11, 2024

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 22, 2023

Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.

Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 22, 2023

Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.

Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.

Journal: PloS one
Published: December 29, 2022

Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection.

Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection.

Journal: Antiviral research
Published: December 12, 2022

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 27, 2022

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.

Journal: Vaccine
Published: May 26, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026